US$ 21.89
glp-1 vs glp-2 Medications for Weight Loss: Semaglutide Tirzepatide vs Retat – Revolution Health & Wellness Main biological actions of GLP-1
Description
The GLP-1 Market size was valued at USD 52.82 billion in 2025 and is expected to grow at a CAGR of 10.9% from 2026 to 2034.

A new study based on real world data found a possible protective effect against multiple sclerosis for some of new weight loss medications.
Evidence-based skincare for weight management without skin compromise.

Significance statement ![Figure][1] ### Competing Interest Statement The authors have declared no competing interest
